Brief: Glycorex Transplantation: Significant Benefits Of Using Intraoperative Glycosorb Treatment For Blood Group Incompatible Pediatric Heart Transplants
15/06/2021 14:02
June 15 (Reuters) - Glycorex Transplantation AB (publ)
GTABb.NGM :
* PUBLICATION SHOWS SIGNIFICANT BENEFITS OF USING
INTRAOPERATIVE
GLYCOSORB ® TREATMENT FOR BLOOD GROUP INCOMPATIBLE PEDIATRIC
HEART TRANSPLANTS
* AMOUNT OF BLOOD PRODUCTS USED DURING HOSPITALIZATION WAS
SIGNIFICANTLY LOWER COMPARED TO PE PATIENTS
Source text for Eikon: ID:nWkr1nMtpX
Further company coverage: GTABb.NGM
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))